These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1099648)
1. [Endocrine ophthalmology. An overview of pathology, classification, and therapy]. Bürgi H; König MP Schweiz Med Wochenschr; 1975 Aug; 105(35):1101-10. PubMed ID: 1099648 [TBL] [Abstract][Full Text] [Related]
2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results]. Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510 [TBL] [Abstract][Full Text] [Related]
3. The Montgomery Lecture, 1980. Endocrine ophthalmopathy. Bouzas AG Trans Ophthalmol Soc U K (1962); 1980; 100(4):511-20. PubMed ID: 7032013 [No Abstract] [Full Text] [Related]
4. Werner's classification of ocular changes in Graves's disease: a review. Lyle WM Am J Optom Physiol Opt; 1978 Feb; 55(2):119-27. PubMed ID: 354401 [No Abstract] [Full Text] [Related]
5. Graves' ophthalmopathy--a clinical review. Carter JN Aust N Z J Ophthalmol; 1990 Aug; 18(3):239-42. PubMed ID: 2261168 [TBL] [Abstract][Full Text] [Related]
9. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids]. Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418 [TBL] [Abstract][Full Text] [Related]
11. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism]. Bürgi U; Gerber H; Peter HJ Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825 [TBL] [Abstract][Full Text] [Related]
12. [Clinical manifestations of thyroid ophthalmopathy]. Fernández Hermida RV; Pinar S; Muruzábal N An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294 [TBL] [Abstract][Full Text] [Related]
13. [Endocrine ophthalmopathy and autoimmune thyroid disease]. Karlsson A; Dahlberg PA; Enoksson P; Boström L; Sääf M; Sjöberg HE; Tallstedt L Nord Med; 1985; 100(11):298-301. PubMed ID: 3840885 [No Abstract] [Full Text] [Related]
14. [Thyroid diseases in sub-Saharan Africa]. Sidibé el H Sante; 2007; 17(1):33-9. PubMed ID: 17897900 [TBL] [Abstract][Full Text] [Related]
16. [Risk factors for occurrence of ophthalmopathy in the course of Graves-Basedow disease]. Sieradzki J; Katra B; Mirkiewicz-Sieradzka B Przegl Lek; 2000; 57(6):321-3. PubMed ID: 11107864 [TBL] [Abstract][Full Text] [Related]